Image pharmaphorum Editor Sales & Marketing Sponsored Lundbeck’s digital strategy and how they manage global and l... Like all large pharmaceutical companies, Lundbeck operates and manages many different digital marketing and information channels. Views & Analysis Should you lie to your granny? When it comes to healthcare there are different opinions about patient care east and west, and as market researchers, understanding this is critical. Views & Analysis Navigating emerging markets – opportunities and challenges f... The pharmaceutical industry is quickly evolving; to stay relevant and competitive, companies need to stay on top of the most recent trends and technologies. Views & Analysis The state of personalised medicine in 2019 Things are good, and they’re getting better. Load more results
Sales & Marketing Sponsored Lundbeck’s digital strategy and how they manage global and l... Like all large pharmaceutical companies, Lundbeck operates and manages many different digital marketing and information channels.
Views & Analysis Should you lie to your granny? When it comes to healthcare there are different opinions about patient care east and west, and as market researchers, understanding this is critical.
Views & Analysis Navigating emerging markets – opportunities and challenges f... The pharmaceutical industry is quickly evolving; to stay relevant and competitive, companies need to stay on top of the most recent trends and technologies.
Views & Analysis The state of personalised medicine in 2019 Things are good, and they’re getting better.
News EU clears first drug therapy for rare disease cALD Neuraxpharm and Minoryx' Nezglyal has become the first approved drug therapy in the EU for rare neurodegenerative disease cALD.
Digital Sponsored Discover a new era of healthcare panel engagement: Grounded ... A new webinar from Konovo will address some of the critical topics impacting today’s healthcare market research industry.
